SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is seeing a wave of bullish sentiment as traders anticipate a breakthrough toward 80,000, driven by excitement over potential institutional buying and upcoming clarity on regulatory developments. While some community members remain cautious about a potential pullback, the prevailing discourse suggests a strong belief that the bear market has concluded and a new cycle is underway.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is attracting significant community attention as investors debate its institutional-grade potential and the impact of perpetual exchange revenue-sharing models on its token supply. Community sentiment is largely polarized, with many discussing its unique buyback mechanics and long-term utility while others warn of potential price volatility and regulatory scrutiny.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as holders discuss its potential to break key resistance levels and reach higher valuations, drawing comparisons to major meme coins. The community remains focused on the brand's long-term growth and its ability to outperform despite recent market volatility.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin is trending as investors focus on an upcoming Supreme Court ruling regarding the Hikma litigation and potential catalysts from the LR-EtEPA platform. Discussions center on the company's path toward potential M&A and the impact of the ongoing Recordati partnership on global commercialization efforts.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

Investors are closely watching natural gas price action for signs of a breakout, balancing record-high heat demand against elevated production and supply levels that have limited recent rallies. While some community members remain optimistic about a potential short squeeze, others warn of the persistent decay associated with leveraged ETFs and remain cautious heading into the upcoming storage reports.

TOSHI

TOSHI is trending as the community speculates on a potential breakout, citing a massive increase in buy wall volume and optimistic technical setups. Holders are actively discussing a possible short squeeze and are waiting for major exchange catalysts to push the meme coin back toward recent highs.

Ethena

Ethena is trending as investors react to a major secured lending facility with FalconX, sparking broader community discussion about the token's role in institutional capital infrastructure. Bulls are highlighting recent price appreciation and institutional interest as signs of momentum, while others closely monitor its correlation to Bitcoin and the broader altcoin landscape.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

PURR is experiencing significant momentum driven by community speculation surrounding potential US regulatory approval for the Hyperliquid exchange and a high-profile stake from Stanley Druckenmiller. Investors are heavily focused on the stock's potential for a short squeeze, citing its limited public float and the significant short interest.

ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

Natural gas traders are actively discussing the impact of mild spring weather and high production levels on the commodity's price, while closely monitoring geopolitical risks in the Middle East. Many are focused on navigating the volatility of leveraged ETFs like KOLD and BOIL, with community debate centering on whether these instruments are suitable for short-term scalping or long-term holds given their tendency for decay.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Investors are closely monitoring Xeris Biopharma ahead of a key investor presentation on September 9th, which is expected to provide critical details on the Phase 3 development program for XP-8121, a once-weekly injectable levothyroxine. The community remains highly focused on the blockbuster potential of this pipeline asset and the company's strong revenue growth, often drawing parallels to other successful biotech stories in the endocrinology space.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Meta Platforms Stock Drops 17% YTD: Should You Buy, Sell or Hold it?

META's 17% YTD drop reflects rising AI costs, weaker cash flow and higher debt, even as AI lifts engagement and ad efficiency across its platforms.

Snap Stock Drops Monday: What's Driving the Move?

Snap Inc. (NYSE: SNAP) shares are trading lower Monday as Wall Street weighs a 9th U.S. Circuit ruling and insider stock sales.read more...

Reddit Strengthens Ad Game Against Meta and Snap: More Upside Ahead?

RDDT's ad growth, AI-powered Reddit Max, and expanding advertiser base strengthen its push against Meta and Snap.


SNAP Stock Is ‘Easiest 5-10x’ Out There, Says Scott Galloway — But CEO Needs To 'Wake Up From Decade-Long Hallucination'

Equity

Galloway said he would buy Snap shares, betting the stock could rise manifold if Spiegel exits the hardware business.


Snap (SNAP) International Revenue Performance Explored

Examine Snap's (SNAP) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Snap Stock Analysis: Buy or Sell?

Snap (NYSE: SNAP) ended its streak of losses in a critically important metric...

Stock Of The Day: Is Snap Breaking Out?

Snap Inc. shares could be breaking out above important resistance. This could be a bullish dynamic that suggests a move higher.read more...

Snap Stock Rallies After Q2 Earnings Beat as Analysts See Improving Ad Revenue Trends

Shares of Snap Inc (NYSE: SNAP) rally after upbeat Q2 results. Analysts revise price targets after Q3 outlook suggests a decline in revenue growth.read more...

SNAP's Q2 Revenues Climb 19% Y/Y, Adjusted EBITDA Surges 505%

SNAP tops revenue guidance as Q2 sales rise 19% and adjusted EBITDA surges 505%, with AI tools, subscriptions and ad growth driving stronger results.

Snap Q2 Earnings Call Highlights Ad Gains and Cash Discipline

SNAP puts free cash flow per share first as ad gains, subscription growth and disciplined Specs spending aim to drive durable cash generation.

This account has been verified as an official SNAP representative.

Verified Account

Nicole Petrosino

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Bullish Sentiment

More bullish - Specs changes the story

Same - still neutral / wait and see

More bearish - pricey hardware, cash burn worries

Already bearish - staying short / avoiding

$2,195 Specs are here. $SNAP says it's the future. Are you a believer or is this just going to burn cash and investors.

Snap ($SNAP) just unveiled its $2,195 Specs AR glasses at AWE. After the announcement, where are you on the stock? 
 
Drop a comment if you own the stock.

Stocktwits

Snap Inc

) just unveiled its $2,195 Specs AR glasses at AWE. After the announcement, where are you on the stock? 
 
Drop a comment if you own the stock.

Feed

News

Sentiment

Earnings

Fundamentals

Info

SNAP Snap Inc

Fundamentals

Connect Stocktwits to ChatGPT

Latest SNAP News